• 2009/2013 - LIPIDENGUE: The role of hepatic lipid membranes and lipid droplets in Dengue virus encapsidation. A gateway to new therapies. (PTDC/QUI-BIQ/112929/2009)
• Structural characterization at the molecular level of vector peptides to transfect macromolecules across lipidic membranes. Membrane-active peptides across disciplines and continents: An integrated approach to find new strategies to fight bacteria, dengue virus and neurodegeneration (MEMPEPACROSS). Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-2009-IRSES), Collaboration with Biomembraes Unit
• Study of the inhibitory action of peptides on the fusion of the virus HIV-1 at the molecular level (PTDC/QUI-BIQ/104787/2008, collaboration with Biomembranes Unit).
• Peptides as drug candidates directed to pain and neurodegeneration (Pep2Brain), EC-FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP), Grant nº 230654
• Toward the development of peptide-based hydrogels for tissue regeneration applications with inherent antibacterial activity. (EC, FP7-PEOPLE-IOF-2008-235154) (FCT, PTDC/SAU-BEB/099142/2008)

(all on-going projects involve collaborations)

• Structural characterization of a drug carrier system by Rayleigh light scattering
• A model for the action of anti-fugi polyenes at the molecular level
• The interaction of kyotorphin with lipidic membranes. Maximizing permeability conditions. (PTDC/SAU-FCT/69493/2006)
• The interaction of Dengue virus proteins with lipids. (PTDC/SAU-FCT/69937/2006)
• The molecular mode of action of antimicrobial peptides and other membrane-active peptides (CRUP-DAAD, Portuguese-German Joint Project A-6/08).
• Elucidating the mechanism of action of cyclotides; ultra-stable proteins from plants. European Comission. PIOF-GA-2008-220318 (joint project with the Institute for Molecular Biosciences, The University of Queensland, Australia)